Literature DB >> 18752323

Hereditary hemochromatosis in the post-HFE era.

John K Olynyk1, Debbie Trinder, Grant A Ramm, Robert S Britton, Bruce R Bacon.   

Abstract

Following the discovery of the HFE gene in 1996 and its linkage to the iron overload disorder hereditary hemochromatosis (HH) there have been profound developments in our understanding of the pathogenesis of the biochemical and clinical manifestations of a number of iron overload disorders. This article provides an update of recent developments and key issues relating to iron homeostasis and inherited disorders of iron overload, with emphasis on HFE-related HH, and is based on the content of the American Association for the Study of Liver Diseases Single-Topic Conference entitled "Hemochromatosis: What has Happened After HFE?" which was held at the Emory Convention Center in Atlanta, September 7-9, 2007.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18752323      PMCID: PMC2548289          DOI: 10.1002/hep.22507

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  140 in total

1.  Sp family of transcription factors is involved in iron-induced collagen alpha1(I) gene expression.

Authors:  I G Ruiz; P de la Torre; T Diaz; E Esteban; J D Morillas; T Muñoz-Yagüe; J A Solís-Herruzo
Journal:  DNA Cell Biol       Date:  2000-03       Impact factor: 3.311

2.  Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?

Authors:  P C Adams
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

3.  Autosomal dominant hereditary hemochromatosis associated with two novel Ferroportin 1 mutations in Spain.

Authors:  V Bach; A Remacha; A Altés; M J Barceló; M A Molina; M Baiget
Journal:  Blood Cells Mol Dis       Date:  2005-10-27       Impact factor: 3.039

4.  Uncommon mutations and polymorphisms in the hemochromatosis gene.

Authors:  J J Pointon; D Wallace; A T Merryweather-Clarke; K J Robson
Journal:  Genet Test       Date:  2000

5.  Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.

Authors:  Ernest Beutler; Vincent J Felitti; James A Koziol; Ngoc J Ho; Terri Gelbart
Journal:  Lancet       Date:  2002-01-19       Impact factor: 79.321

6.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.

Authors:  Gaël Nicolas; Caroline Chauvet; Lydie Viatte; Jean Louis Danan; Xavier Bigard; Isabelle Devaux; Carole Beaumont; Axel Kahn; Sophie Vaulont
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

7.  Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis.

Authors:  Linda M Fletcher; Jeannette L Dixon; David M Purdie; Lawrie W Powell; Darrell H G Crawford
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

Review 8.  Pathology of hepatic iron overload.

Authors:  Yves Deugnier; Bruno Turlin
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

Review 9.  Iron, the HFE gene, and hepatitis C.

Authors:  Christoph Eisenbach; Sven G Gehrke; Wolfgang Stremmel
Journal:  Clin Liver Dis       Date:  2004-11       Impact factor: 6.126

10.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis.

Authors:  Antonella Roetto; George Papanikolaou; Marianna Politou; Federica Alberti; Domenico Girelli; John Christakis; Dimitris Loukopoulos; Clara Camaschella
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

View more
  16 in total

Review 1.  Modulation of hepcidin to treat iron deregulation: potential clinical applications.

Authors:  Nicole L Blanchette; David H Manz; Frank M Torti; Suzy V Torti
Journal:  Expert Rev Hematol       Date:  2015-12-15       Impact factor: 2.929

2.  Transferrin and H-ferritin involvement in brain iron acquisition during postnatal development: impact of sex and genotype.

Authors:  Brian Chiou; Elizabeth B Neely; Dillon S Mcdevitt; Ian A Simpson; James R Connor
Journal:  J Neurochem       Date:  2019-08-22       Impact factor: 5.372

3.  Iron: an emerging factor in colorectal carcinogenesis.

Authors:  Anita C G Chua; Borut Klopcic; Ian C Lawrance; John K Olynyk; Debbie Trinder
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

Review 4.  Endocrine dysfunction in hereditary hemochromatosis.

Authors:  C Pelusi; D I Gasparini; N Bianchi; R Pasquali
Journal:  J Endocrinol Invest       Date:  2016-03-07       Impact factor: 4.256

Review 5.  Pathogenesis of liver cirrhosis.

Authors:  Wen-Ce Zhou; Quan-Bao Zhang; Liang Qiao
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

6.  HFE C282Y homozygotes are at increased risk of breast and colorectal cancer.

Authors:  Nicholas J Osborne; Lyle C Gurrin; Katrina J Allen; Clare C Constantine; Martin B Delatycki; Christine E McLaren; Dorota M Gertig; Gregory J Anderson; Melissa C Southey; John K Olynyk; Lawrie W Powell; John L Hopper; Graham G Giles; Dallas R English
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

Review 7.  Genetic mechanisms and modifying factors in hereditary hemochromatosis.

Authors:  Günter Weiss
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-11-17       Impact factor: 46.802

8.  Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis.

Authors:  Subhashini Chandrasekharan; Emily Pitlick; Christopher Heaney; Robert Cook-Deegan
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822

9.  Utility and limitations of Hepascore and transient elastography to detect advanced hepatic fibrosis in HFE hemochromatosis.

Authors:  John K Olynyk; Martin B Delatycki; Sim Yee Ong; Tiffany Khoo; Amanda J Nicoll; Lyle Gurrin; Thomas Worland; Puraskar Pateria; Louise E Ramm; Adam Testro; Gregory J Anderson; Richard Skoien; Lawrie W Powell; Grant A Ramm
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

10.  Impact of iron overload on interleukin-10 levels, biochemical parameters and oxidative stress in patients with sickle cell anemia.

Authors:  Maritza Cavalcante Barbosa; Talyta Ellen Jesus Dos Santos; Geane Félix de Souza; Lívia Coêlho de Assis; Max Victor Carioca Freitas; Romélia Pinheiro Gonçalves
Journal:  Rev Bras Hematol Hemoter       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.